Bufotenin: Difference between revisions
Appearance
| [checked revision] | [pending revision] |
MDElliottMD (talk | contribs) Added empty fda_max parameter to MedTemplate call |
MDElliottMD (talk | contribs) Tier 2 taxonomy consolidation: merge Classic Psychedelics into Classical Psychedelics (Serotonergic) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 22: | Line 22: | ||
| dosing = | | dosing = | ||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 32: | Line 31: | ||
}} | }} | ||
[[Category: | |||
[[Category:Psychedelics]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Tryptamines]] | |||
Latest revision as of 17:26, 21 May 2026
Psychedelic, Tryptamine
Bufotenin
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Psychedelic, Tryptamine
Common uses
Pharmacy
Pharmacology
Purported mechanism
5-HT2A agonist; 5-HT3 antagonist